STUDY OF CLINICAL AND LABORATORY PROFILE OF PATIENTS WITH ADRENAL MASS.

Aims and objectives: AIM of this study was to observe and correlate clinical and laboratory profile of patients with adrenal mass. The objective was to study clinical and laboratory profile of patients with adrenal mass with the secondary objective to establish the etiological diagnosis with adrenal mass Methods: This observational study was carried out at tertiary care government hospital in north India from Jul 2020 to June 2022. Based on prevalence 4.4 of the disease as per previous study sample size for 95% confidence level & 5% precision works out 43. The inclusion Criteria were patients detected to have adrenal mass or symptoms related with adrenal mass. The exclusion criteria were any pre-existing known malignancy other than adrenal gland. Subsequent to enrolment the demographic data, clinical data, laboratory data, hormonal assays and radiological data was recorded as per predesigned proforma. The adrenal CT imaging protocol consists of three phases together are used for calculating absolute percentage washout and/or relative percentage washout to differentiate lipid-poor adenomas from primary carcinoma and metastases. Results: The mean age was 39± 15.41. Majority of patients were males 35(77.8%). 86.7% subjects had no comorbidity, 7.9 % had HTN. 6.7% patients were noted to have clinical cushings whereas in 4.4% subject acanthosis nigricans and goiter was seen. On Overnight dexamethasone suppression test, 16/45 patients were observed with value higher than <2.01 ug/dl, similar was the case with low dose dexamethasone suppression test. There was a significant rise in the mean plasma free metanephrine and urinary metanephrine noted in 12/ 45 patients. The minimum size of adrenal mass detected in the USG abdomen was 2.5 cm. The minimum size of adrenal mass detected in the CT abdomen was 1.21 cm. There is a significant association noted between absolute percentage washout (APW) outcome and hormonal activity with p-value <0.001. Conclusion: 6.7 % had features of cushing's disease and 4.4 % had acanthosis nigricans. On hormonal assays elevated metanephrine levels were seen in 26% subjects. On hormonal assays of ONDST and LDDST 35.5 % subjects were seen with elevated levels. Other hormonal assays aldosterone, renin and ACTH were normal. CECT was sensitive to identify a small adrenal mass up to 0.633 cm. 34 % of adrenal mass were hyper functional and 2 % were found malignant in this study.

Rare presentation of right Adrenal Mass: Extramedullary haematopoiesis in a patient with Thalassaemia Intermedia / Journal of the ASEAN Federation of Endocrine Societies

@#Extramedullary hematopoiesis (EMH) is a rare cause of adrenal mass. We present a 44-year-old woman who has thalassaemia intermedia, referred to Endocrinology clinic for huge adrenal mass. Along with a paraspinal lesion discovered in this patient, the leading diagnosis was EMH. The patient was treated with hypertransfusion and hydroxyurea, which led to a reduction in the size of the right adrenal mass and paraspinal mass. This case highlights the challenges in managing this rare condition. Although EMH is a rare cause of adrenal mass, the diagnosis must be considered in any patient with a history of a congenital hemolytic disorder, to avoid unnecessary surgical procedures.

Pheochromocytoma Crisis Triggered by Extra-Corporal Membrane Oxygenation Explantation.

Context: We report a 59 year old Chinese woman in pheochromocytoma multisystem crisis and was initially stabilised with ECMO; subsequently she manifested rapid cyclical fluctuation of blood pressure precipitated by explantation of ECMO. Case Description: Madam L presented with chest pain and giddiness. She developed cardiogenic shock refractory to double inotropes and intra-aortic balloon pump (IABP); but responded to Extra-Corporal Membrane Oxygenation (ECMO). Subsequently rapid cyclical blood pressure fluctuations from 230 mmHg to 50mmHg systolic occurred after explantation of ECMO. Biochemically urine metanephrines and normetanephrines were more than seven times above upper limit of normal. Imaging confirmed the presence of right adrenal mass likely pheochromocytoma. She was started on alpha blockade and underwent an uneventful laparotomy with removal of a 10 cm adrenal mass. Histology confirmed a large cystic pheochromocytoma with haemorrhagic components. Conclusions: Pheochromocytoma crisis should be suspected in cases of unexplained shock or Takutsubo cardiomyopathy; early recognition and ECMO support can be life-saving. In addition, ECMO explantation can trigger rapid cyclical blood pressure fluctuations and should be closely monitored for.

Endoscopic Ultrasound-Guided Fine-Needle Aspiration of the Adrenal Glands: Analysis of 21 Patients

BACKGROUND/AIMS: Endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) cytology of adrenal masses helps in etiological diagnosis. The aim of this study was to evaluate the diagnostic yield of EUS-FNA of adrenal masses in cases where other imaging methods failed and/or were not feasible. METHODS: Twenty-one consecutive patients with adrenal masses, in whom adrenal FNA was performed because conventional imaging modalities failed and/or were not feasible, were prospectively evaluated over a period of 3 years. RESULTS: Of the 21 patients (mean age, 56+/-12.2 years; male:female ratio, 2:1), 12 had pyrexia of unknown origin and the other nine underwent evaluation for metastasis. The median lesion size was 2.4x1.6 cm. Ten patients were diagnosed with tuberculosis (shown by the presence of caseating granulomas [n=10] and acid-fast bacilli [n=4]). Two patients had EUS-FNA results suggestive of histoplasmosis. The other patients had metastatic lung carcinoma (n=6), hepatocellular carcinoma (n=1), and adrenal lipoma (n=1) and adrenal myelolipoma (n=1). EUS results were not suggestive of any particular etiology. No procedure-related adverse events occurred. CONCLUSIONS: EUS-FNA is a safe and effective method for evaluating adrenal masses, and it yields diagnosis in cases where tissue diagnosis is impossible or has failed using conventional imaging modalities.

Pheochromocytoma in Indian patients: A retrospective study.

Aim: To review the clinical experience on pheochromocytoma in Indian subset of patients. Materials and Methods: Ten patients diagnosed with pheochromocytoma between 2001 and 2010 at our institute were retrospectively studied for clinical, laboratory, radiological and surgical data. Results: A total of 10 patients (5 females and 5 males) aged between 23 and 64 years diagnosed as pheochromocytoma were managed at our institute. The most frequent symptoms were abdominal pain (90%) and hypertension (50%). The tumor was intra-adrenal in 70% and extra-adrenal in 30%. 20% were on right side and 50% on left side. CT scan of abdomen was the most widely used method for tumor localization. Among laboratory assays, 24-h urinary vanillylmandelic acid (VMA) was the most widely used. None of our patients were found to be associated with hereditary pheochromocytoma syndrome. All hypertensive patients were preoperatively treated with phenoxybenzamine and propranolol. All underwent explorative laparotomy and adrenelectomy. Malignancy was reported in 40% of cases and these received adjuvant radiotherapy. Among hypertensive patients, surgery caused remission of hypertension in 60%. All patients were followed up with 24-h urinary VMA levels and CT scan of abdomen regularly. Survival ranged from 1 to 9 years. Conclusions: The present study confirms that the clinical presentation of pheochromocytoma is variable and non-specific. Often the tumor is discovered incidentally. Though pheochromocytoma is a rare tumor, proper evaluation, preoperative preparation and complete surgical excision are important for its management.

A Case of an Adrenocortical Carcinoma with Pulmonary Embolism as the Initial Manifestation

The annual incidence of a first episode of deep vein thrombosis or pulmonary embolism (PE) in the general population is 120 per 100,000. Cancer is associated with an approximately 4- to 7-fold higher risk of thrombosis. Adrenocortical carcinoma (ACC) is a rare type of malignancy, accounting for 0.02% of all cancers reported annually. Approximately 40% of ACCs are nonsecretory. Most patients with nonsecreting tumors have clinical manifestations related to tumor growth (e.g., abdominal or flank pain). Often the adrenal mass is detected by chance via radiographic imaging. As a result, most ACC patients are diagnosed at an advanced stage and have a poor prognosis. Herein, we report a case of a 54-year-old woman who was admitted to our emergency department complaining of dyspnea. She was diagnosed with ACC accompanied by thrombi in the pulmonary artery and inferior vena cava. We performed a left adrenalectomy and administered adjuvant radiotherapy. The patient is currently receiving warfarin and adjuvant mitotane therapy. She was incidentally diagnosed with ACC, with PE as the initial manifestation.

CT features of adrenal pheochromocytoma: Evaluation with clinical and pathological correlation.

Objective: To evaluate CT features of adrenal pheochromocytoma with clinical and histopathological correlation. Methods: A retrospective study was approved by the ethics committee. Forty-four patients with proven adrenal pheochromocytoma from January 2002- December 2007 at our institution were included. Only 10 out of the 44 had available pre-operative computed tomography (CT). All 10 CT were interpreted independently by two abdominal radiologists, with correlation with clinical and histopathological analysis. Results: All 10 patients had unilateral adrenal pheochromocytoma. Three were men and 7 were women. The mean age of patients was 45.1 years old. Eight out of 10 patients presented with hypertension. Four patients presented with neuroendocrine symptoms such as palpitation and diaphoresis. Other symptoms were palpable abdominal mass, headache and gastrointestinal symptoms (nausea, vomiting or abdominal pain). Pre-operative biochemistry tests for pheochromocytoma were performed in 8 patients. The tumor size varied from 2-15 cm in diameter. CT features of pheochromocytoma of this study showed 1 tumor of pure solid mass (2 cm tumor size) and 9 tumors of complex cystic masses. The range of density values at the solid part of tumors was 25-53 HU on non-contrast phase CT and the mean was about 41.4 HU. All 10 tumors showed enhancement of the solid part. Intratumoral hemorrhage and calcifications were detected. No intratumoral fatty component was detected. Conclusion: CT findings of adrenal pheochromocytoma were typical heterogeneous soft tissue density mass and moderate enhancement. Tumors with cystic component and hemorrhage were common in our study. CT was useful for tumor characterization in patient with nonclassic clinical manifestation of pheochromocytoma and also for pre-operative management.

Diagnóstico e tratamento das massas adrenais clinicamente silenciosas - revisão sistemática de literatura / Diagnoses and treatment of clinically unapparent adrenal masses - systematic literature review

Introdução: Massas adrenais clinicamente silenciosas, diagnosticadas sem intenção, incidentalmente, durante exame de imagem realizado para outras condições clínicas ("incidentaloma") têm sido cada vez mais encontradas devido ao constante progresso dos métodos de imagem e de sua indicação relativamente elástica. São inúmeras as causas, diagnósticos e tratamentos dessas massas, levando o médico a definir se a massa é hormonalmente ativa e se há risco de a lesão ser maligna. Entretanto os métodos para esclarecimento dessas questões ainda não estão bem definidos. Objetivo: Avaliar as melhores formas de diagnóstico, tratamento e seguimento da lesão incidental de adrenal. Método: Foi realizada uma revisão sistemática da literatura até outubro de 2004, analisando seu grau de evidência. Resultados: Foram encontrados dois trabalhos de revisão sistemática que selecionaram e estudaram artigos até setembro de 2003 e, então, adicionados ao estudo mais 28 artigos provenientes de revisão bibliográfica sistemática até outubro de 2004. Conclusões: Em geral os "incidentalomas" são não funcionantes, mas a avaliação endócrina demonstrou que não é raro o achado de hiperfunção hormonal subclínica, reforçando a necessidade de dosagem de certas substâncias, como metanefrinas, realização do teste de supressão de dexametasona em baixas dosagens e mensuração da relação da aldosterona plasmática/atividade plasmática da renina. "Incidentalomas" não funcionantes menores de 4cm devem ser observados entre 4 e 6cm devem ser analisados por suas características de imagem maiores de 6 cm devem ser operados. "Incidentalomas" funcionantes devem ser submetidos à adrenalectomia. Massas adrenais não operadas devem ser acompanhadas por dois anos, por meio de exames de imagem e de função.

Usefulness of F-18 FDG PET/CT in Adrenal Incidentaloma: Differential Diagnosis of Adrenal Metastasis in Oncologic Patients / 핵의학분자영상

PURPOSE: We have evaluated characteristics of adrenal masses incidentally observed in nonenhanced F-18 FDG PET/CT of the oncologic patients and the diagnostic ability of F-18 FDG PET/CT to differentiate malignant from benign adrenal masses. MATERIALS AND METHODS: Between Mar 2005 and Aug 2008, 75 oncologic patients (46 men, 29 women; mean age, 60.8+/-10.2 years; range, 35-87 years) with 89 adrenal masses incidentally found in PET/CT were enrolled in this study. For quantitative analysis, size (cm), Hounsfield unit (HU), maximum standardized uptake value (SUVmax), SUVratio of all 89 adrenal masses were measured. SUVmax of the adrenal mass divided by SUVliver, which is SUVmax of the segment 8, was defined as SUVratio. The final diagnosis of adrenal masses was based on pathologic confirmation, radiologic evaluation (HU<0 : benign), and clinical decision. RESULTS: Size, HU, SUVmax, and SUVratio were all significantly different between benign and malignant adrenal masses.(P < 0.05) And, SUVratio was the most accurate parameter. A cut-off value of 1.0 for SUVratio provided 90.9% sensitivity and 75.6% specificity. In small adrenal masses (1.5 cm or less), only SUVratio had statistically significant difference between benign and malignant adrenal masses. Similarly a cut-off value of 1.0 for SUVratio provided 80.0% sensitivity and 86.4% specificity. CONCLUSION: F-18 FDG PET/CT can offer more accurate information with quantitative analysis in differentiating malignant from benign adrenal masses incidentally observed in oncologic patients, compared to nonenhanced CT.

Primary Retroperitoneal Malignant Gastrointestinal Stromal Tumor Mimicking Adrenal Mass

Gastrointestinal stromal tumor (GIST) is the most common non-epithelial tumor in the gastrointestinal tract. Although GIST occurs mainly in the gastrointestinal tract, it also occurs, rarely, in non-gastrointestinal tract and in this case, it is often named as extra-gastrointestinal stromal tumor (EGIST). We experienced a 68-year-old male patient who had been diagnosed preoperatively with accidentaloma of the left adrenal gland by computed tomography, and finally diagnosed as primary retroperitoneal malignant GIST, postoperatively. The operation was performed via anterior abdominal approach, and complete surgical resection was done for a 7 cm sized retroperitoneal tumor near the left adrenal gland. Primary retroperitoneal malignant GIST was the final pathologic diagnosis and the size of the tumor was 6.5 cm and the mitotic count was 7 per high-power field. Diffuse strong positive staining for c-kit protein, CD34 and negative staining for desmin were observed in a immunohistochemistry test. We report here the unusual case of primary retroperitoneal malignant GIST mimicking adrenal mass.

Incidentaloma suprarrenal: a propósito de un caso / Adrenal incidentaloma. apropos of a case

El hallazgo de masas suprarrenales descubiertas de forma accidental ante la utilización de técnicas de imagen abdominales para el estudiode otras patologías es un problema cada vez màs frecuente.Se presenta el caso de una mujer de 44 años de edad a la que se descubrió una masa en la glándula suprarrenal derecha de formaaccidental. Su aparición requiere un estudio de funcionalidad hormonal y estudios con técnicas de imagen para determinar su naturaleza,tamaño y tratamiento...

Abdominal masses discovered accidentally during abdominal imaging perfomed for other reasons, are a common problem. We report a case of a 44 years old woman with a right adrenal masse incidentally discovered, this study requires the exclusion of hypersecreting lesions and imaging studies to determine its nature, size and treatment.

Long-term Follow up of Congenital Adrenal Hyperplasia Patients with Hyponatremia

Congenital adrenal hyperplasia (CAH) caused by 21-hydroxylase deficiency is an autosomal recessive disease, which leads to cortisol and aldosterone deficiency and hyperandrogenism. Typical medical treatment includes oral glucocorticoid and mineralocorticoid administration to suppress adrenal androgens and to compensate for adrenal steroid deficiencies. Usually, they have been managed with hydrocortisone (cortisone) and fludrocortisone (florinef). However, some patients stopped taking medicine without the doctor's consent. Among these patients, four cases of CAH patients showing the presence of hyponatremia as an initial electrolyte disorder were found with adrenal adenoma discovered by abdominal computerized tomography scan. Hypersecretion of adrenocorticotrophic hormone may play a role in the development of adrenal tumor and chronic poor compliance to therapy appears to be associated with development of the tumor. Two cases were managed with adrenalectomy because of increasing adrenal tumor size and virilization. Whereas the other two cases did not increase in size and were observed without adrenalectomy. Therefore, it is important that patients with CAH maintain steroid medication to avoid the appearance of adrenal tumor.

Antígeno nuclear de proliferação celular em tumores de adrenal

Fez-se um estudo imunohistoquímico do antígeno nuclear de proliferação celular (PCNA) em 26 adenomas e 24 carcinomas de adrenal através da técnica da avidina-biotina-peroxidase. O índice de marcação (IP) do PCNA, definido com o número de células marcadas/1000 contadas, foi em média de 77,4± 66,1 (mediana - 63,5) para os adenomas enquanto que para os carcinomas foi 215,8± 56,0 (mediana - 217,5) (p 0,0001). Estabelecendo-se o IP de 100 o marcador (para a discriminação de carcinomas dos adenomas) o marcador exibiu sensibilidade, especificidade e valor preditivo positivo seguintes, respectivamente: 100%, 69% e 75%.

Metastatic renal cell carcinoma in the contralateral adrenal gland of a 65 year old male 10 years after radical nephrectomy

A case of a 65 year old male from Tondo, Manila with metastatic Renal Cell Carcinoma (RCC) in the contralateral adrenal gland is presented. He underwent a left radical nephrectomy back in May 1992 after which he remained asymptomatic. Only the finding of a right adrenal mass 10 years later would stand to challenge his "cured" state. The steps that lead to the diagnosis and the subsequent management of his case are discussed here. (Author)